Sims K - Search Results

1

Cerebrovascular involvement in Fabry disease: current status of knowledge.

Kolodny E, Fellgiebel A, Hilz MJ, Sims K, Caruso P, Phan TG, Politei J, Manara R, Burlina A. Kolodny E, et al. Among authors: sims k. Stroke. 2015 Jan;46(1):302-13. doi: 10.1161/STROKEAHA.114.006283. Epub 2014 Dec 9. Stroke. 2015. PMID: 25492902 Review. No abstract available.

2

Stroke in Fabry disease frequently occurs before diagnosis and in the absence of other clinical events: natural history data from the Fabry Registry.

Sims K, Politei J, Banikazemi M, Lee P. Sims K, et al. Stroke. 2009 Mar;40(3):788-94. doi: 10.1161/STROKEAHA.108.526293. Epub 2009 Jan 15. Stroke. 2009. PMID: 19150871

3

Early diagnosis of peripheral nervous system involvement in Fabry disease and treatment of neuropathic pain: the report of an expert panel.

Burlina AP, Sims KB, Politei JM, Bennett GJ, Baron R, Sommer C, Møller AT, Hilz MJ. Burlina AP, et al. BMC Neurol. 2011 May 27;11:61. doi: 10.1186/1471-2377-11-61. BMC Neurol. 2011. PMID: 21619592 Free PMC article. Review.

4

Enzyme replacement therapy stabilized white matter lesion progression in Fabry disease.

Fellgiebel A, Gartenschläger M, Wildberger K, Scheurich A, Desnick RJ, Sims K. Fellgiebel A, et al. Among authors: sims k. Cerebrovasc Dis. 2014;38(6):448-56. doi: 10.1159/000369293. Epub 2014 Dec 11. Cerebrovasc Dis. 2014. PMID: 25502511 Free article. Clinical Trial.

5

Determinants of white matter hyperintensity burden in patients with Fabry disease.

Rost NS, Cloonan L, Kanakis AS, Fitzpatrick KM, Azzariti DR, Clarke V, Lourenco CM, Germain DP, Politei JM, Homola GA, Sommer C, Üçeyler N, Sims KB. Rost NS, et al. Neurology. 2016 May 17;86(20):1880-6. doi: 10.1212/WNL.0000000000002673. Epub 2016 Apr 20. Neurology. 2016. PMID: 27164662 Free PMC article.

6

Case records of the Massachusetts General Hospital. Case 8-2011. A 32-year-old woman with seizures and cognitive decline.

Sims KB, Cole AJ, Sherman JC, Caruso PA, Snuderl M. Sims KB, et al. N Engl J Med. 2011 Mar 17;364(11):1062-74. doi: 10.1056/NEJMcpc1013927. N Engl J Med. 2011. PMID: 21410375 No abstract available.

7

Early cerebellar degeneration in twins with infantile neuroaxonal dystrophy.

Barlow JK, Sims KB, Kolodny EH. Barlow JK, et al. Among authors: sims kb. Ann Neurol. 1989 Apr;25(4):413-5. doi: 10.1002/ana.410250416. Ann Neurol. 1989. PMID: 2540694

8

Agalsidase beta treatment is associated with improved quality of life in patients with Fabry disease: findings from the Fabry Registry.

Watt T, Burlina AP, Cazzorla C, Schönfeld D, Banikazemi M, Hopkin RJ, Martins AM, Sims K, Beitner-Johnson D, O'Brien F, Feldt-Rasmussen U. Watt T, et al. Among authors: sims k. Genet Med. 2010 Nov;12(11):703-12. doi: 10.1097/GIM.0b013e3181f13a4a. Genet Med. 2010. PMID: 20885332 Free article.

9

Identification of Fabry Disease in a Tertiary Referral Cohort of Patients with Hypertrophic Cardiomyopathy.

Maron MS, Xin W, Sims KB, Butler R, Haas TS, Rowin EJ, Desnick RJ, Maron BJ. Maron MS, et al. Am J Med. 2018 Feb;131(2):200.e1-200.e8. doi: 10.1016/j.amjmed.2017.09.010. Epub 2017 Sep 21. Am J Med. 2018. PMID: 28943383

10

Risk factors for severe clinical events in male and female patients with Fabry disease treated with agalsidase beta enzyme replacement therapy: Data from the Fabry Registry.

Hopkin RJ, Cabrera G, Charrow J, Lemay R, Martins AM, Mauer M, Ortiz A, Patel MR, Sims K, Waldek S, Warnock DG, Wilcox WR. Hopkin RJ, et al. Among authors: sims k. Mol Genet Metab. 2016 Sep;119(1-2):151-9. doi: 10.1016/j.ymgme.2016.06.007. Epub 2016 Jun 13. Mol Genet Metab. 2016. PMID: 27510433 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

388 results

Search Page